News features

October 31, 2017

Sanofi turns to artificial intelligence to beat flu

October 19, 2017

BERG Supports PurpleStride 2017 in Fight Against Pancreatic Cancer

October 4, 2017

CSO Ranga Sarangarajan, CAO Slava Akmaev explain how embrace of AI has led to promising drug candidates

October 4, 2017

CEO Niven Narain Sheds Light on New Prostate Cancer Diagnostic Test Developed for DoD

September 5, 2017

CEO Niven Narain Discusses AI, AstraZeneca Partnership on BBC’s “Talking Business”

August 29, 2017

AstraZeneca Teams Up with BERG to Tackle Neurological Disease

August 28, 2017

AstraZeneca taps AI for drug discovery in deal with BERG

July 7, 2017

The Next Frontier for A.I.? Drug Research

June 26, 2017

Wall Street Journal: How AI Is Transforming Drug Creation

June 2, 2017

Pharma–Advocacy Partnerships: How the BERG–debra Partnership Helps EB Patients

March 10, 2017

Frontline Genomics talks to Ranga Sarangarajan about our AI guided GBM trials

March 6, 2017

PharmExec.com discusses big data with BERG’s Slava Akmaev

January 12, 2017

BD Taps BERG’s AI Platform to Reduce Medication Non-Adherence

January 5, 2017

The Economist: Will artificial intelligence help to crack biology?

August 19, 2016

An Industry Overdue for Disruption

August 10, 2016

BERG Wages Hope for Pancreatic Cancer

July 7, 2016

Tech.co: BERG Aims to Lower Cost of Medicine with Artificial Intelligence

April 25, 2016

Frontline Genomics Talk to BERG’s CEO Niven R. Narain

April 22, 2016

Fortune: Feature on BERG Clinical trials

April 6, 2016

Mendelspod talks to Niven R Narain, CEO
Wired UK Feature on BERG

March 31, 2016

Wired UK Feature on BERG